Incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases treated with bisphosphonates and/or denosumab: some comments and questions
Acta Clin Belg
.
2018 Apr;73(2):163-164.
doi: 10.1080/17843286.2017.1389473.
Epub 2017 Nov 7.
Authors
Vittorio Fusco
1
,
Maura Rossi
1
,
Iolanda De Martino
1
,
Manuela Alessio
1
,
Antonella Fasciolo
1
,
Gianmauro Numico
1
Affiliation
1
a Azienda Ospedaliera di Alessandria , Alessandria , Italy.
PMID:
29111914
DOI:
10.1080/17843286.2017.1389473
No abstract available
Publication types
Letter
Comment
MeSH terms
Bone Density Conservation Agents
Bone Neoplasms
Denosumab*
Diphosphonates*
Humans
Incidence
Osteonecrosis
Substances
Bone Density Conservation Agents
Diphosphonates
Denosumab